Management of Thrombocytopenia in Advanced Liver Disease

Thrombocytopenia (defined as a platelet count <150×109/L) is a well-known complication in patients with liver cirrhosis and has been observed in 76% to 85% of patients. Significant thrombocytopenia (platelet count <50×109/L to 75×109/L) occurs in approximately 13% of patients with cirrhosis. T...

Full description

Saved in:
Bibliographic Details
Main Authors: VGR Gangireddy, PC Kanneganti, S Sridhar, S Talla, T Coleman
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Canadian Journal of Gastroenterology and Hepatology
Online Access:http://dx.doi.org/10.1155/2014/532191
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850162744669503488
author VGR Gangireddy
PC Kanneganti
S Sridhar
S Talla
T Coleman
author_facet VGR Gangireddy
PC Kanneganti
S Sridhar
S Talla
T Coleman
author_sort VGR Gangireddy
collection DOAJ
description Thrombocytopenia (defined as a platelet count <150×109/L) is a well-known complication in patients with liver cirrhosis and has been observed in 76% to 85% of patients. Significant thrombocytopenia (platelet count <50×109/L to 75×109/L) occurs in approximately 13% of patients with cirrhosis. Thrombocytopenia can negatively impact the care of patients with severe liver disease by potentially interfering with diagnostic and therapeutic procedures. Multiple factors can contribute to the development of thrombocytopenia including splenic platelet sequestration, immunological processes, bone marrow suppression by chronic viral infection, and reduced levels or activity of the hematopoietic growth factor thrombopoietin. The present review focuses on the etiologies and management options for severe thrombocytopenia in the setting of advanced liver disease.
format Article
id doaj-art-f93bc6ebba4a45c8a2acff134aab9cbf
institution OA Journals
issn 2291-2789
2291-2797
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series Canadian Journal of Gastroenterology and Hepatology
spelling doaj-art-f93bc6ebba4a45c8a2acff134aab9cbf2025-08-20T02:22:28ZengWileyCanadian Journal of Gastroenterology and Hepatology2291-27892291-27972014-01-01281055856410.1155/2014/532191Management of Thrombocytopenia in Advanced Liver DiseaseVGR Gangireddy0PC Kanneganti1S Sridhar2S Talla3T Coleman4Georgia Regents University, Augusta, GeorgiaHelena Regional Medical Center, Helena, Arkansas, USAGeorgia Regents University, Augusta, GeorgiaLuzhou Medical College, Luzhou, ChinaArchbold Medical Center, Thomasville, USAThrombocytopenia (defined as a platelet count <150×109/L) is a well-known complication in patients with liver cirrhosis and has been observed in 76% to 85% of patients. Significant thrombocytopenia (platelet count <50×109/L to 75×109/L) occurs in approximately 13% of patients with cirrhosis. Thrombocytopenia can negatively impact the care of patients with severe liver disease by potentially interfering with diagnostic and therapeutic procedures. Multiple factors can contribute to the development of thrombocytopenia including splenic platelet sequestration, immunological processes, bone marrow suppression by chronic viral infection, and reduced levels or activity of the hematopoietic growth factor thrombopoietin. The present review focuses on the etiologies and management options for severe thrombocytopenia in the setting of advanced liver disease.http://dx.doi.org/10.1155/2014/532191
spellingShingle VGR Gangireddy
PC Kanneganti
S Sridhar
S Talla
T Coleman
Management of Thrombocytopenia in Advanced Liver Disease
Canadian Journal of Gastroenterology and Hepatology
title Management of Thrombocytopenia in Advanced Liver Disease
title_full Management of Thrombocytopenia in Advanced Liver Disease
title_fullStr Management of Thrombocytopenia in Advanced Liver Disease
title_full_unstemmed Management of Thrombocytopenia in Advanced Liver Disease
title_short Management of Thrombocytopenia in Advanced Liver Disease
title_sort management of thrombocytopenia in advanced liver disease
url http://dx.doi.org/10.1155/2014/532191
work_keys_str_mv AT vgrgangireddy managementofthrombocytopeniainadvancedliverdisease
AT pckanneganti managementofthrombocytopeniainadvancedliverdisease
AT ssridhar managementofthrombocytopeniainadvancedliverdisease
AT stalla managementofthrombocytopeniainadvancedliverdisease
AT tcoleman managementofthrombocytopeniainadvancedliverdisease